| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/17/2012 | US8221757 Monoclonal antibodies against extracellular loops of C5aR |
| 07/17/2012 | CA2700319C Carbonates for use in the preparation of derivatives of dioxan-2-alkyl carbamates |
| 07/17/2012 | CA2518676C Use of diazoxide in the treatment of ischemia retinae |
| 07/17/2012 | CA2391392C Methods for screening candidate drugs that disrupt mif and jab1 interaction, mif and jab1 complex, antibodies and uses thereof |
| 07/17/2012 | CA2355976C Vascular endothelial cell growth factor antagonists and uses thereof |
| 07/12/2012 | WO2012094300A2 Methods of treating age-related macular degeneration |
| 07/12/2012 | WO2012093753A1 Artificial saliva comprising hyaluronic acid |
| 07/12/2012 | WO2012093101A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd) |
| 07/12/2012 | WO2012092849A1 Polyamide-amine dendrimer or derivative thereof-math1 gene nano particle and use thereof in treatment of hearing loss |
| 07/12/2012 | WO2012032209A3 Pharmaceutical composition for the treatment of dry eye |
| 07/12/2012 | US20120178820 Method for treating arthritis |
| 07/12/2012 | US20120178806 Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle |
| 07/12/2012 | US20120178798 Substituted cyclopentanes having prostaglandin activity |
| 07/12/2012 | US20120178795 Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| 07/12/2012 | US20120178794 RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders |
| 07/12/2012 | US20120178785 Derivatives of n-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators |
| 07/12/2012 | US20120178768 Phosphodiesterase inhibitor treatment |
| 07/12/2012 | US20120178752 Rho kinase inhibitors |
| 07/12/2012 | US20120178740 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 07/12/2012 | US20120178734 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES |
| 07/12/2012 | US20120178714 Phosphorus-containing Compounds & Uses Thereof |
| 07/12/2012 | US20120178708 Phenethylsulfone isoindoline derivatives and their use |
| 07/12/2012 | US20120178682 GB1 Peptidic Compounds and Methods for Making and Using the Same |
| 07/12/2012 | US20120178681 Bipiperidinyl compounds, compositions, containing such compounds and methods of treatment |
| 07/12/2012 | US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/12/2012 | US20120177759 Compositions and methods for increasing lifespan and health span |
| 07/12/2012 | US20120177741 Positively-charged poly (d,l-lactide-co-glycolide) nanoparticles and fabrication methods of the same |
| 07/12/2012 | US20120177725 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds |
| 07/12/2012 | US20120177717 Sustained drug delivery system |
| 07/12/2012 | US20120177716 Methods for Making Controlled Delivery Devices Having Zero Order Kinetics |
| 07/12/2012 | US20120177704 Crystalline anti-human il-12 antibodies |
| 07/12/2012 | US20120177703 Solid linear oligo-or poly-e-caprolactone |
| 07/12/2012 | US20120177695 Bioerodible Silicon-Based Devices for Delivery of Therapeutic Agents |
| 07/12/2012 | US20120177694 Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom |
| 07/12/2012 | US20120177614 Culture method to obtain and maintain a pure or enriched population of mammalian neural stem cells and/or neural/progenitor cells that are prone to differentiate into oligodendrocyte-lineage cells in vitro |
| 07/12/2012 | US20120177596 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 07/12/2012 | US20120177590 Soft anticholinergic esters |
| 07/12/2012 | CA2823665A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd) |
| 07/12/2012 | CA2823549A1 Methods of treating age-related macular degeneration |
| 07/11/2012 | EP2474549A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type I inhibitors |
| 07/11/2012 | EP2473501A1 Compounds as tyrosine kinase modulators |
| 07/11/2012 | EP2473173A2 Treatment of glaucoma and other retinopathies with gangliosides |
| 07/11/2012 | EP2473065A1 A xanthophyl composition containing macular pigments and a process for its preparation |
| 07/11/2012 | EP2242491B1 Novel use of 3,3'-diindolylmethane |
| 07/11/2012 | EP1487778B1 Substituted 4-aminocyclohexanols |
| 07/11/2012 | EP1472224B1 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
| 07/11/2012 | EP1470121B1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/11/2012 | CN1762381B Ophthalmic compositions containing galactomannan polymers and borate |
| 07/11/2012 | CN102574922A Anti - TGF - BETA receptor type II single domain antibodies |
| 07/11/2012 | CN102574857A Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 07/11/2012 | CN102574844A Maleic acid salt and crystal thereof |
| 07/11/2012 | CN102573831A Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 07/11/2012 | CN102573813A 持续药物传递系统 Sustained drug delivery system |
| 07/11/2012 | CN102573800A Ophthalmic drug delivery system containing phospholipid and cholesterol |
| 07/11/2012 | CN102558231A Ophthalmic compositions for treating ocular hypertension |
| 07/11/2012 | CN102558173A Compound inhibiting conduction of WNT signal, and composition and application thereof |
| 07/11/2012 | CN102558167A Thiazolidine derivant with GK and PPAR double excitation activity |
| 07/11/2012 | CN102558164A Benzopyrone estrogen receptor (ER) modulator |
| 07/11/2012 | CN102558128A Extract containing prodelphinidin and procyanidin of ginkgo and its preparation method and application |
| 07/11/2012 | CN102558022A Substituted isoindoline-1,3-dione derivative |
| 07/11/2012 | CN102557976A Bromfenac organic salt, and preparation method thereof, composition thereof and application thereof |
| 07/11/2012 | CN102552889A Biologically sterilizing eye drop preparation |
| 07/11/2012 | CN102552777A Medicament for treating herpes simplex keratitis and preparation method thereof |
| 07/11/2012 | CN102552730A Health product for diabetic fundus hemorrhage |
| 07/11/2012 | CN102552699A Preparation method of dendrobium candidum ultrafine powder |
| 07/11/2012 | CN102552639A Traditional Chinese medicine possessing function for alleviating asthenopia and its preparation method |
| 07/11/2012 | CN102552549A Composition for improving visual fatigue and preparation method and application thereof |
| 07/11/2012 | CN102552521A Traditional Chinese medicine composition for treating behcet disease |
| 07/11/2012 | CN102552457A Application of medicinal composition of amino acid and extracts |
| 07/11/2012 | CN102552451A Artemisinin wine and preparation method thereof |
| 07/11/2012 | CN102552364A Chinese herbal medicine for treating chronic conjunctivitis and preparation method thereof |
| 07/11/2012 | CN102552363A Preparation method for mother chrysanthemum extract |
| 07/11/2012 | CN102552356A Quality control method of sugar-free erigeron breviscapine mixture |
| 07/11/2012 | CN102552351A Preparation method and production method of Chuanxiong decoction integrated new formulation |
| 07/11/2012 | CN102552310A Meniere disease curative |
| 07/11/2012 | CN102552217A Trimetazidine sustained release capsule and preparation method thereof |
| 07/11/2012 | CN102552208A Daidzein solid dispersion micro-pill capsule and preparation method thereof |
| 07/11/2012 | CN102552114A Metronidazole ophthalmic gel and preparation method and application thereof |
| 07/11/2012 | CN102552106A Steroid intraocular implants having an extended sustained release for a period of greater than two months |
| 07/10/2012 | US8217138 Anti-inflammatory compounds and uses thereof |
| 07/10/2012 | US8216599 Administering hydroxytyrosol and oleuropein in a ratio of 1:1-200:1 |
| 07/10/2012 | US8216584 Imaging, diagnosis and treatment of disease |
| 07/10/2012 | US8216569 Vascular endothelial growth factor 2 |
| 07/10/2012 | CA2592995C 1-thio-d-glucitol derivatives |
| 07/10/2012 | CA2519898C Oral administration of cyclic protein tyrosine kinase inhibitors |
| 07/10/2012 | CA2446356C Use of compositions for treating rosacea |
| 07/10/2012 | CA2444704C Synthesis and evaluation of phthalimide mimics as anti-angiogenic agents |
| 07/10/2012 | CA2417960C Method of using diketopiperazines and composition containing them |
| 07/10/2012 | CA2400916C Aminoadamantane derivatives as therapeutic agents |
| 07/05/2012 | WO2012092510A2 Ocular drug delivery system |
| 07/05/2012 | WO2012092320A2 Eye treatment |
| 07/05/2012 | WO2012091449A2 Pharmaceutical composition comprising phosphorylated grasp for treating cystic fibrosis |
| 07/05/2012 | WO2012091278A2 Nanoemulsion-type ophthalmic composition |
| 07/05/2012 | WO2012090994A1 Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate |
| 07/05/2012 | WO2012090985A1 Aqueous ophthalmic composition |
| 07/05/2012 | WO2012090170A1 Products for ophtalmic use |
| 07/05/2012 | WO2012089137A1 Arylurea compound, intermediate and use thereof |
| 07/05/2012 | WO2012089053A1 Method for inhibiting myopia and use of adenylate cyclase inhibitor as drug for inhibiting myopia |
| 07/05/2012 | WO2012051313A3 Ophthalmic formulations, methods of manufacture and methods of normalizing meibomian gland secretions |
| 07/05/2012 | US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta |